SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-213137
Filing Date
2021-07-12
Accepted
2021-07-12 16:53:01
Documents
12
Period of Report
2021-07-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d134421d8ka.htm   iXBRL 8-K/A 25175
  Complete submission text file 0001193125-21-213137.txt   153199

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmea-20210707.xsd EX-101.SCH 2904
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20210707_lab.xml EX-101.LAB 18836
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20210707_pre.xml EX-101.PRE 11853
5 EXTRACTED XBRL INSTANCE DOCUMENT d134421d8ka_htm.xml XML 4069
Mailing Address 726 MAIN STREET REDWOOD CITY CA 94063
Business Address 726 MAIN STREET REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40335 | Film No.: 211086010
SIC: 2834 Pharmaceutical Preparations